Citation

Rezk MNN, Beshreda GM, Meshref DA, Abdelzaher WY, Batiha GES, Hafiz AA, Althumairy D, Aljarba NH, Welson NN. Ecotoxicol. Environ. Saf. 2023; 256: e114847.

Copyright

(Copyright © 2023, Academic Press)

DOI

10.1016/j.ecoenv.2023.114847

PMID

37023646

Abstract

Hydrogen cyanamide (Dormex) is a plant growth regulator that is classified as a highly toxic poison. There are no definite investigations to help in its diagnosis and follow-up. This study aimed to investigate the role of hypoxia-inducible factor-1α (HIF-1α) in the diagnosis, prediction, and follow-up of Dormex-intoxicated patients. Sixty subjects were equally divided into two groups: group A, the control group, and group B, the Dormex group. Clinical and laboratory evaluations, including arterial blood gases (ABG), prothrombin concentration (PC), the international normalized ratio (INR), a complete blood count (CBC), and HIF-1α, were done on admission. CBC and HIF-1α were repeated for group B 24 and 48 h after admission to track abnormalities. Group B also had brain computed tomography (CT). Patients with abnormal CT scans were referred for brain magnetic resonance imaging (MRI). Significant differences in levels of HB, WBCs, and platelets were also detected in group B up to 48 h after admission, as white blood cells (WBCs) rose with time and hemoglobin (HB) and platelets diminished. The results described a highly significant difference in HIF-1α between the groups, and it depended on the clinical condition; therefore, it can be used in the prediction and follow-up of patients up to 24 h after admission.

Language: en

Keywords

Dormex; Follow up; Hydrogen cyanamide; Hypoxia-inducible factor-1α (HIF-1α)